{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T08:06:20Z","timestamp":1784102780363,"version":"3.55.0"},"reference-count":106,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomed Rep"],"DOI":"10.3892\/br.2026.2168","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T08:40:57Z","timestamp":1781772057000},"page":"1-8","source":"Crossref","is-referenced-by-count":0,"title":["Cariprazine\u2011induced obsessive\u2011compulsive symptoms in a patient with bipolar II disorder: A case report"],"prefix":"10.3892","volume":"25","author":[{"given":"Suwanan","family":"Pornlertkochakorn","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine, Srinakharinwirot University, Nakhon Nayok 26120, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krittisak","family":"Anuroj","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Faculty of Medicine, Srinakharinwirot University, Nakhon Nayok 26120, Thailand"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"key20260715102410_b1-BR-25-2-02168","author":"Ayd"},{"key":"key20260715102410_b2-BR-25-2-02168"},{"key":"key20260715102410_b3-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"703","DOI":"10.4088\/jcp.v67n0503","article-title":"The brown longitudinal obsessive compulsive study: Clinical features and Symptoms of the sample at intake","volume":"67","author":"Pinto","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"key20260715102410_b4-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1017\/thg.2014.77","article-title":"Genetic and environmental contributions to stability in adult obsessive compulsive behavior","volume":"18","author":"Zilh\u00e3o","year":"2015","journal-title":"Twin Res Hum Genet"},{"issue":"673595","key":"key20260715102410_b5-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.673595","article-title":"Obsessive-compulsive symptoms, polygenic risk score, and thalamic development in children from the brazilian high-risk cohort for mental conditions (BHRCS)","volume":"12","author":"Ravagnani Salto","year":"2021","journal-title":"Front Psychiatry"},{"key":"key20260715102410_b6-BR-25-2-02168","author":"Kaplan"},{"key":"key20260715102410_b7-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"4583","DOI":"10.1038\/s41380-020-01007-8","article-title":"Toward a neurocircuit-based taxonomy to guide treatment of obsessive-compulsive disorder","volume":"26","author":"Shephard","year":"2021","journal-title":"Mol Psychiatry"},{"key":"key20260715102410_b8-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1007\/s00787-015-0723-3","article-title":"Socio-demographic and psychopathological risk factors in obsessive-compulsive disorder: Epidemiologic study of school population","volume":"13","author":"Moreso","year":"2013","journal-title":"Int J Clin Health Psychol"},{"issue":"42","key":"key20260715102410_b9-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.1186\/s12991-017-0165-z","article-title":"A multilevel longitudinal study of obsessive compulsive symptoms in adolescence: Male gender and emotional stability as protective factors","volume":"16","author":"Stavropoulos","year":"2017","journal-title":"Ann Gen Psychiatry"},{"issue":"561266","key":"key20260715102410_b10-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.561266","article-title":"Impacts of stressful life events and traumatic experiences on onset of obsessive-compulsive disorder","volume":"11","author":"Murayama","year":"2020","journal-title":"Front Psychiatry"},{"key":"key20260715102410_b11-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1038\/s41380-024-02489-6","article-title":"Genome-Wide association study of obsessive-compulsive Symptoms including 33,943 individuals from the general population","volume":"29","author":"Strom","year":"2024","journal-title":"Mol Psychiatry"},{"issue":"116155","key":"key20260715102410_b12-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2024.116155","article-title":"A prospective longitudinal investigation of the trajectory of obsessive-compulsive symptoms during adolescence","volume":"341","author":"Jagannathan","year":"2024","journal-title":"Psychiatry Res"},{"issue":"510","key":"key20260715102410_b13-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-014-0510-8","article-title":"Second generation antipsychotic-induced obsessive-compulsive symptoms in schizophrenia: A review of the experimental literature","volume":"16","author":"Fonseka","year":"2014","journal-title":"Curr Psychiatry Rep"},{"key":"key20260715102410_b14-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1080\/14737175.2022.2117614","article-title":"Antiseizure medication-induced obsessive-compulsive disorder and tic disorder: A pragmatic review","volume":"22","author":"Doobay","year":"2022","journal-title":"Expert Rev Neurother"},{"key":"key20260715102410_b15-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.parkreldis.2011.01.009","article-title":"Dopamine agonist-triggered pathological behaviors: Surveillance in the PD clinic reveals high frequencies","volume":"17","author":"Hassan","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"issue":"603631","key":"key20260715102410_b16-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/603631","article-title":"Dopamine agonists and pathologic behaviors","volume":"2012","author":"Kelley","year":"2012","journal-title":"Parkinsons Dis"},{"issue":"318","key":"key20260715102410_b17-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2014.00318","article-title":"Impulsive and compulsive behaviors in Parkinson's disease","volume":"6","author":"Zhang","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"key20260715102410_b18-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2174\/157015912799362724","article-title":"Clozapine-induced obsessive-compulsive Symptoms in schizophrenia: A critical review","volume":"10","author":"Schirmbeck","year":"2012","journal-title":"Curr Neuropharmacol"},{"key":"key20260715102410_b19-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"649","DOI":"10.4103\/0253-7613.100406","article-title":"Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia","volume":"44","author":"Kulkarni","year":"2012","journal-title":"Indian J Pharmacol"},{"key":"key20260715102410_b20-BR-25-2-02168","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/am.am_105_23","article-title":"Prevalence and pattern of olanzapine emergent obsessive-compulsive Symptoms: A cross-sectional study","volume":"21","author":"Mishra","year":"2024","journal-title":"Apollo Med"},{"key":"key20260715102410_b21-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0377-1237(08)80069-X","article-title":"Drug induced obsessive compulsive disorder in Schizophrenia","volume":"64","author":"Saini","year":"2008","journal-title":"Med J Armed Forces India"},{"key":"key20260715102410_b22-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/01.jcp.0000227809.60664.6d","article-title":"Quetiapine-induced obsessive-compulsive Symptoms: A series of five cases","volume":"26","author":"Stamouli","year":"2006","journal-title":"J Clin Psychopharmacol"},{"key":"key20260715102410_b23-BR-25-2-02168","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1176\/ajp.156.11.1834-a","article-title":"Effectiveness of olanzapine treatment for severe obsessive-compulsive disorder","volume":"156","author":"Marazziti","year":"1999","journal-title":"Am J Psychiatry"},{"key":"key20260715102410_b24-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1001\/archpsyc.57.8.794","article-title":"A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder","volume":"57","author":"McDougle","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"key20260715102410_b25-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"73","DOI":"10.4088\/jcp.v66n0110","article-title":"Quetiapine augmentation in obsessive-compulsive disorder resistant to serotonin reuptake inhibitors: An open-label study","volume":"66","author":"Bogan","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"key20260715102410_b26-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1176\/appi.focus.20230009","article-title":"The CANMAT and ISBD guidelines for the treatment of bipolar disorder: Summary and a 2023 update of evidence","volume":"21","author":"Keramatian","year":"2023","journal-title":"Focus (Am Psychiatr Publ)"},{"key":"key20260715102410_b27-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1017\/S1092852916000043","article-title":"Mechanism of action of cariprazine","volume":"21","author":"Stahl","year":"2016","journal-title":"CNS Spectr"},{"key":"key20260715102410_b28-BR-25-2-02168","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1176\/appi.ajp-rj.2024.190302","article-title":"A brief review of cariprazine","volume":"19","author":"Oldak","year":"2024","journal-title":"Am J Psychiatry Resid J"},{"issue":"1442699","key":"key20260715102410_b29-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2024.1442699","article-title":"Exploring cariprazine as a treatment option for varied depression symptom clusters","volume":"15","author":"Peju\u0161kovi\u0107","year":"2024","journal-title":"Front Psychiatry"},{"key":"key20260715102410_b30-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jad.2024.04.084","article-title":"Effects of cariprazine on reducing symptoms of irritability, hostility, and agitation in patients with manic or mixed episodes of bipolar I disorder","volume":"358","author":"Citrome","year":"2024","journal-title":"J Affect Disord"},{"issue":"e945411","key":"key20260715102410_b31-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.945411","article-title":"Cariprazine in psychiatry: A comprehensive review of efficacy, safety, and therapeutic potential","volume":"30","author":"Koziej","year":"2024","journal-title":"Med Sci Monit"},{"key":"key20260715102410_b32-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"957","DOI":"10.2147\/NDT.S301225","article-title":"Safety and tolerability of cariprazine in patients with Schizophrenia: A pooled analysis of eight phase II\/III studies","volume":"17","author":"Barab\u00e1ssy","year":"2021","journal-title":"Neuropsychiatr Dis Treat"},{"key":"key20260715102410_b33-BR-25-2-02168"},{"issue":"e04084","key":"key20260715102410_b34-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.4084","article-title":"A case series of serious and unexpected adverse drug reactions under treatment with cariprazine","volume":"9","author":"Heck","year":"2021","journal-title":"Clin Case Rep"},{"issue":"727666","key":"key20260715102410_b35-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2021.727666","article-title":"Case report: cariprazine in a patient with Schizophrenia, substance abuse, and cognitive dysfunction","volume":"12","author":"Rodriguez Cruz","year":"2021","journal-title":"Front Psychiatry"},{"key":"key20260715102410_b36-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"398","DOI":"10.9758\/cpn.2022.20.2.398","article-title":"Add-on cariprazine in patients with long-term clozapine treatment and treatment resistant Schizophrenia: Two cases of psychotic deterioration and pisa Syndrome","volume":"20","author":"Weise","year":"2022","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"key20260715102410_b37-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1097\/JCP.0000000000001645","article-title":"Cariprazine-associated obsessive-compulsive Symptoms in a patient with bipolar disorder: Potential mechanisms of D3 receptors","volume":"43","author":"Pariwatcharakul","year":"2023","journal-title":"J Clin Psychopharmacol"},{"key":"key20260715102410_b38-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jad.2023.11.076","article-title":"Mining and analysis of adverse event signals of Cariprazine based on the real-world data of FAERS database","volume":"347","author":"Zhu","year":"2024","journal-title":"J Affect Disord"},{"key":"key20260715102410_b39-BR-25-2-02168","author":"Stahl"},{"key":"key20260715102410_b40-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1176\/appi.focus.20200051","article-title":"Contrasting typical and atypical antipsychotic drugs","volume":"19","author":"Meltzer","year":"2021","journal-title":"Focus (Am Psychiatr Publ)"},{"issue":"1569416","key":"key20260715102410_b41-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2025.1569416","article-title":"Benzos (as) needed: Research into as-needed and intermittent benzodiazepines for anxiety is required for comprehensive best prescribing practices","volume":"16","author":"Krieger","year":"2025","journal-title":"Front Psychiatry"},{"issue":"20451253221082386","key":"key20260715102410_b42-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.1177\/20451253221082386","article-title":"Experiences with benzodiazepine use, tapering, and discontinuation: An Internet survey","volume":"12","author":"Reid Finlayson","year":"2022","journal-title":"Ther Adv Psychopharmacol"},{"key":"key20260715102410_b43-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"e605","DOI":"10.4088\/JCP.14r09758","article-title":"Early onset of response with selective serotonin reuptake inhibitors in obsessive-compulsive disorder: A meta-analysis","volume":"77","author":"Issari","year":"2016","journal-title":"J Clin Psychiatry"},{"issue":"19ac13182","key":"key20260715102410_b44-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.19ac13182","article-title":"Pharmacotherapy for treatment-resistant obsessive-compulsive disorder","volume":"81","author":"Kayser","year":"2020","journal-title":"J Clin Psychiatry"},{"key":"key20260715102410_b45-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3109\/13651501.2012.755206","article-title":"A prospective population-based cohort study of the prevalence, incidence and impact of obsessive-compulsive symptomatology","volume":"17","author":"Fineberg","year":"2013","journal-title":"Int J Psychiatry Clin Pract"},{"key":"key20260715102410_b46-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jpsychires.2013.10.021","article-title":"Late-onset obsessive-compulsive disorder: Risk factors and correlates","volume":"49","author":"Frydman","year":"2014","journal-title":"J Psychiatr Res"},{"key":"key20260715102410_b47-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jaac.2017.10.016","article-title":"Brain structural correlates of subclinical obsessive-compulsive Symptoms in healthy children","volume":"57","author":"Su\u00f1ol","year":"2018","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key20260715102410_b48-BR-25-2-02168","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5114\/fpn.2021.115645","article-title":"Obsessive compulsive syndrome in a patient treated by cariprazine in the course of schizophrenia with predominantly negative symptoms","volume":"37","author":"Ko\u017amin-Burzy\u0144ska","year":"2022","journal-title":"Pharmacotherapy in Psychiatry and Neurology\/Farmakoterapia w Psychiatrii i Neurologii"},{"key":"key20260715102410_b49-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/s0278-5846(00)00146-9","article-title":"On the role of prefrontal cortex glutamate for the antithetical phenomenology of obsessive compulsive disorder and attention deficit hyperactivity disorder","volume":"25","author":"Carlsson","year":"2001","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"key20260715102410_b50-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neuropharm.2018.09.004","article-title":"Reduced cortical serotonin 5-HT2A receptor binding and glutamate activity in high compulsive drinker rats","volume":"143","author":"Mora","year":"2018","journal-title":"Neuropharmacology"},{"key":"key20260715102410_b51-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.2147\/NDT.S211703","article-title":"Investigating the role of glutamate in obsessive-compulsive disorder: Current perspectives","volume":"16","author":"Karthik","year":"2020","journal-title":"Neuropsychiatr Dis Treat"},{"key":"key20260715102410_b52-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/pcn.13760","article-title":"Serotonergic underpinnings of obsessive-compulsive disorder: A systematic review and meta-analysis of neuroimaging findings","volume":"79","author":"Pastre","year":"2025","journal-title":"Psychiatry Clin Neurosci"},{"key":"key20260715102410_b53-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.neuroimage.2008.04.233","article-title":"In vivo PET study of 5HT(2)A serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder","volume":"42","author":"Perani","year":"2008","journal-title":"NeuroImage"},{"key":"key20260715102410_b54-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1017\/S1461145705005055","article-title":"Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei","volume":"8","author":"Adams","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"key20260715102410_b55-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.psychres.2016.09.031","article-title":"Induced obsessive compulsive symptoms (OCS) in Schizophrenia patients under Atypical 2 antipsychotics (AAPs): Review and hypotheses","volume":"246","author":"Grillault Laroche","year":"2016","journal-title":"Psychiatry Res"},{"key":"key20260715102410_b56-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/00004714-200210000-00004","article-title":"Risperidone-induced obsessive-compulsive symptoms: A series of six cases","volume":"22","author":"Alevizos","year":"2002","journal-title":"J Clin Psychopharmacol"},{"key":"key20260715102410_b57-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0278-5846(03)00039-3","article-title":"Obsessive-compulsive symptoms induced by atypical antipsychotics. A review of the reported cases","volume":"27","author":"Lykouras","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"key20260715102410_b58-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"S89","DOI":"10.1089\/104454603322126386","article-title":"Risperidone-induced obsessive-compulsive symptoms in two children","volume":"13 (Suppl 1)","author":"Diler","year":"2003","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"134","key":"key20260715102410_b59-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.4088\/jcp.v59n0308e","article-title":"Possible dose-response relationship for risperidone in obsessive-compulsive disorder","volume":"59","author":"Baker","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"key20260715102410_b60-BR-25-2-02168","author":"Stahl"},{"key":"key20260715102410_b61-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1007\/s00213-014-3516-3","article-title":"D2 and D3 dopamine receptor affinity predicts effectiveness of antipsychotic drugs in obsessive-compulsive disorders: A metaregression analysis","volume":"231","author":"Ducasse","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"key20260715102410_b62-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1055\/s-2000-8360","article-title":"Serotonin and dopamine antagonism in obsessive-compulsive disorder: Effect of atypical antipsychotic drugs","volume":"33","author":"Ramasubbu","year":"2000","journal-title":"Pharmacopsychiatry"},{"issue":"1124112","key":"key20260715102410_b63-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.3389\/fnsyn.2023.1124112","article-title":"Latest updates on the serotonergic system in depression and anxiety","volume":"15","author":"Lin","year":"2023","journal-title":"Front Synaptic Neurosci"},{"key":"key20260715102410_b64-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/s0091-3057(02)01037-7","article-title":"5-HT1A receptor activity disrupts spontaneous alternation behavior in rats","volume":"74","author":"Seibell","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"issue":"1078983","key":"key20260715102410_b65-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2022.1078983","article-title":"Impact of specific serotonin receptor modulation on restricted repetitive behaviors","volume":"16","author":"Alvarez","year":"2022","journal-title":"Front Behav Neurosci"},{"key":"key20260715102410_b66-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/BF02244438","article-title":"Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorder","volume":"105","author":"Lesch","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"key20260715102410_b67-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1001\/archpsyc.1991.01810300052007","article-title":"5-Hydroxytryptamine1A receptor responsivity in obsessive-compulsive disorder. Comparison of patients and controls","volume":"48","author":"Lesch","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"key20260715102410_b68-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1017\/S0924270800036875","article-title":"Obsessive compulsive disorder: Opportunities within and beyond the serotonergic domain","volume":"9","author":"Zohar","year":"1997","journal-title":"Acta Neuropsychiatr"},{"key":"key20260715102410_b69-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/acps.13567","article-title":"Antipsychotics and obsessive-compulsive disorder\/obsessive-compulsive symptoms: A pharmacovigilance study of the FDA adverse event reporting system","volume":"148","author":"Burk","year":"2023","journal-title":"Acta Psychiatr Scand"},{"issue":"1852","key":"key20260715102410_b70-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56663-7","article-title":"Striatal dopamine D2\/D3 receptor regulation of human reward processing and behaviour","volume":"16","author":"Osugo","year":"2025","journal-title":"Nat Commun"},{"key":"key20260715102410_b71-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neuroscience.2010.12.008","article-title":"Activation of dopamine D3 receptors inhibits reward-related learning induced by cocaine","volume":"176","author":"Kong","year":"2011","journal-title":"Neuroscience"},{"key":"key20260715102410_b72-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/sj.mp.4001617","article-title":"Obsessive-compulsive disorder phenotypes: Implications for genetic studies","volume":"10","author":"Miguel","year":"2005","journal-title":"Mol Psychiatry"},{"key":"key20260715102410_b73-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3349\/ymj.2006.47.4.443","article-title":"The genetic studies of obsessive-compulsive disorder and its future directions","volume":"47","author":"Kim","year":"2006","journal-title":"Yonsei Med J"},{"issue":"111428","key":"key20260715102410_b74-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2025.111428","article-title":"Dopamine D3 receptor gene is associated with obsessive-compulsive disorder and antidepressant response","volume":"140","author":"Zai","year":"2025","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"154","key":"key20260715102410_b75-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00596-9","article-title":"Impulsive-compulsive behaviour in early Parkinson's disease is determined by apathy and dopamine receptor D3 polymorphism","volume":"9","author":"Theis","year":"2023","journal-title":"NPJ Parkinsons Dis"},{"key":"key20260715102410_b76-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.physbeh.2011.04.055","article-title":"Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease","volume":"104","author":"Ahlskog","year":"2011","journal-title":"Physiol Behav"},{"key":"key20260715102410_b77-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.1111\/ejn.14177","article-title":"Pharmacological insights into impulsive-compulsive spectrum disorders associated with dopaminergic therapy","volume":"50","author":"Napier","year":"2019","journal-title":"Eur J Neurosci"},{"issue":"110051","key":"key20260715102410_b78-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2024.110051","article-title":"Involvement of dopamine D3 receptor in impulsive choice decision-making in male rats","volume":"257","author":"Shen","year":"2024","journal-title":"Neuropharmacology"},{"issue":"142","key":"key20260715102410_b79-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-025-00996-z","article-title":"Impulsive-compulsive behaviours and striatal neuroactivity in mildly parkinsonian rats under D2\/3 agonist and L-DOPA treatment","volume":"11","author":"Wolfschlag","year":"2025","journal-title":"NPJ Parkinsons Dis"},{"key":"key20260715102410_b80-BR-25-2-02168","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.21474\/IJAR01\/19213","article-title":"Cariprazine augmentation to SSRIS in treating a case of treatment-resistant obsessive-compulsive disorder in an adolescent female","volume":"12","author":"Bansal","year":"2024","journal-title":"Int J Adv Res"},{"key":"key20260715102410_b81-BR-25-2-02168","author":"Martiadis"},{"key":"key20260715102410_b82-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/YIC.0000000000000284","article-title":"Rapid improvement of obsessive-compulsive disorder associated with schizophrenia with cariprazine add-on in a subject under paliperidone long-acting injection: A case report","volume":"35","author":"De Berardis","year":"2020","journal-title":"Int Clin Psychopharmacol"},{"key":"key20260715102410_b83-BR-25-2-02168","doi-asserted-by":"crossref","first-page":"114","DOI":"10.14744\/DAJPNS.2024.00247","article-title":"Obsessive-compulsive disorder in a woman with high-functioning autism","volume":"37","author":"Dolfi","year":"2024","journal-title":"Dusunen Adam J Psychiatr Neurol Sci"},{"key":"key20260715102410_b84-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.1080\/10673220303949","article-title":"Heterogeneity of obsessive-compulsive disorder: A literature review","volume":"11","author":"C","year":"2003","journal-title":"Harvard review of psychiatry"},{"issue":"8578","key":"key20260715102410_b85-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26178578","article-title":"Biomarkers of obsessive-compulsive disorder subtypes: A literature review","volume":"26","author":"Proshina","year":"2025","journal-title":"Int J Mol Sci"},{"issue":"152352","key":"key20260715102410_b86-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2022.152352","article-title":"Treatment-resistant OCD: Pharmacotherapies in adults","volume":"120","author":"Van Roessel","year":"2023","journal-title":"Compr Psychiatry"},{"key":"key20260715102410_b87-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1017\/S0033291713000470","article-title":"Age of onset in obsessive-compulsive disorder: Admixture analysis with a large sample","volume":"44","author":"Anholt","year":"2014","journal-title":"Psychol Med"},{"key":"key20260715102410_b88-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"672","DOI":"10.2174\/1570159X16666180426151746","article-title":"Diagnostic issues in early-onset obsessive-compulsive disorder and their treatment implications","volume":"17","author":"Burchi","year":"2019","journal-title":"Curr Neuropharmacol"},{"key":"key20260715102410_b89-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1053\/comp.2000.9009","article-title":"Phenotypic differences in early- and late-onset obsessive-compulsive disorder","volume":"41","author":"Sobin","year":"2000","journal-title":"Compr Psychiatry"},{"key":"key20260715102410_b90-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.eurpsy.2008.01.002","article-title":"Obsessive-compulsive disorder: Influence of age at onset on comorbidity patterns","volume":"23","author":"de Mathis","year":"2008","journal-title":"Eur Psychiatry"},{"key":"key20260715102410_b91-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/da.20597","article-title":"Early onset of obsessive-compulsive disorder and associated comorbidity","volume":"26","author":"Janowitz","year":"2009","journal-title":"Depress Anxiety"},{"key":"key20260715102410_b92-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.jad.2015.10.051","article-title":"Comorbidity variation in patients with obsessive-compulsive disorder according to symptom dimensions: Results from a large multicentre clinical sample","volume":"190","author":"Torres","year":"2016","journal-title":"J Affect Disord"},{"key":"key20260715102410_b93-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1503\/jpn.190028","article-title":"Neural bases of the clinical and neurocognitive differences between earlyand late-onset obsessive-compulsive disorder","volume":"45","author":"Kim","year":"2020","journal-title":"J Psychiatry Neurosci"},{"key":"key20260715102410_b94-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jad.2021.11.005","article-title":"Distinct alterations of amygdala subregional functional connectivity in early- and late-onset obsessive-compulsive disorder","volume":"298","author":"Cao","year":"2022","journal-title":"J Affect Disord"},{"key":"key20260715102410_b95-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.1017\/S0033291722003129","article-title":"Cortical gyrification differences between early- and late-onset obsessive-compulsive disorder: Neurobiological evidence for neurodevelopmentally distinct subtypes","volume":"53","author":"Park","year":"2023","journal-title":"Psychol Med"},{"key":"key20260715102410_b96-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jaac.2015.01.011","article-title":"Assessment and management of treatment-refractory obsessive-compulsive disorder in children","volume":"54","author":"Bloch","year":"2015","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"key20260715102410_b97-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.21037\/tp.2019.10.02","article-title":"Obsessive-compulsive disorder in children and adolescents: epidemiology, diagnosis and management","volume":"9 (Suppl 1)","author":"Nazeer","year":"2020","journal-title":"Transl Pediatr"},{"key":"key20260715102410_b98-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychires.2024.02.009","article-title":"Early-onset obsessive-compulsive disorder: Sociodemographic and clinical characterization of a large outpatient cohort","volume":"172","author":"Girone","year":"2024","journal-title":"J Psychiatr Res"},{"key":"key20260715102410_b99-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"83","DOI":"10.12809\/eaap2557","article-title":"Disillusionment mediates the associations between perceived stressors and affective symptoms in Thai medical students: A cross-sectional survey","volume":"35","author":"Wungvivatchareon","year":"2025","journal-title":"East Asian Arch Psychiatry"},{"key":"key20260715102410_b100-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"146","DOI":"10.12809\/eaap2515","article-title":"Factor structure and convergent validity of perceived psychosocial stressor questionnaire: A thai measure of subjective adversities","volume":"35","author":"Anuroj","year":"2025","journal-title":"East Asian Arch Psychiatry"},{"key":"key20260715102410_b101-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.2147\/PRBM.S420771","article-title":"Moderation effects of positive core belief and social-emotional responsiveness on the relationship between cyberbullying victimization and affective Symptoms","volume":"16","author":"Nisu","year":"2023","journal-title":"Psychol Res Behav Manag"},{"key":"key20260715102410_b102-BR-25-2-02168","first-page":"S58","article-title":"Effects of cyberbullying and coping strategies on depression","volume":"105 (Suppl 1)","author":"Anuroj","year":"2022","journal-title":"J Med Assoc Thai"},{"key":"key20260715102410_b103-BR-25-2-02168","author":"Musthafa"},{"issue":"139","key":"key20260715102410_b104-BR-25-2-02168","doi-asserted-by":"publisher","DOI":"10.1186\/s12905-019-0836-9","article-title":"\u2018Living like I am in Thailand\u2019: Stress and coping strategies among Thai migrant masseuses in Oslo, Norway","volume":"19","author":"Tschirhart","year":"2019","journal-title":"BMC Women's Health"},{"key":"key20260715102410_b105-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1093\/scan\/nss036","article-title":"Culture shapes electrocortical responses during emotion suppression","volume":"8","author":"Murata","year":"2013","journal-title":"Soc Cogn Affect Neurosci"},{"key":"key20260715102410_b106-BR-25-2-02168","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4137\/JCNSD.S38359","article-title":"Evidence-based assessment of obsessive-compulsive disorder","volume":"8","author":"Rapp","year":"2016","journal-title":"J Cent Nerv Syst Dis"}],"container-title":["Biomedical Reports"],"original-title":[],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T07:24:20Z","timestamp":1784100260000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/br.2026.2168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":106,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6,18]]}},"URL":"https:\/\/doi.org\/10.3892\/br.2026.2168","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]}}}